You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.
The widely dispersed health system is integrating the Congenica platform into its clinical and research workflows to uncover genetic bases for rare conditions.
The multi-stage drive to create a next-generation computing system will support a new pathogen research center that promises to create 7,500 jobs and advance biomedicine.
With a new CEO and Brazilian distributor, the Finnish firm is looking at additional Latin American and Asian markets and increased support for COVID-19 sequencing.
Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.
In a keynote to the AMIA Informatics Summit, the NCI director said precision oncology has created new challenges in data analysis and management.
The startup has developed software to automate polygenic risk score generation for hospitals and labs using microarray or sequencing data.
In two recent papers, the UK startup demonstrated the integration of polygenic risk scoring into primary care screening and workflows.
Called AtacWorks, the software removes noise from sequencing so low-cell-count, low-coverage, or low-quality ATAC-seq data can still be useful.
With a new CEO, the Swiss startup expects to have its consumer-facing mobile app ready by midyear.
With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.